5-Bromo-2-methyl-2H-pyrazolo[3,4-b]pyridine, 95.0%, 10g

3'-pyrrolidinomethyl-3,4,5-trifluorobenzophenone, 97.0%, 1g

2-(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethanol, 95.0%, 250mg

2,6-Diethoxybenzoic acid, 95+%, 1g

3-(ethoxycarbonyl)-1-(4-ethoxyphenyl)-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 2g

N-(4-Hydroxycyclohexyl)acetamide, 95.0%, 100g

GC capillary column ROTI®Cap-XLB, 60 m, 1 Piece(s)

2-Chloro-3-iodoquinoline, 95.0%, 2.5g

(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,3-dimethylphenyl)propanoic acid, 98%, 1g

ethyl 5-amino-1-(2,4-difluorophenyl)-1H-pyrazole-3-carboxylate, 95.0%, 1g

Strontium 2,2'-((5-carboxylato-4-(carboxylatomethyl)-3-cyanothiophen-2-yl)azanediyl)diacetate, 95.0%, 10g

4-Cyano-2-fluorobenzyl bromide, 98.0%, 100g

2,2',7,7'-Tetrakis-(N,N-di-4-methoxyphenylamino)-9,9'-spirobifluorene>98.0%(HPLC)1g